髂股静脉支架在髂静脉压迫综合征中的应用体会  

Application experience of iliofemoral vein stenting in iliac venous compression syndrome

作　　者：刘振斌[1] 王刚[1] 王博文 李梦虎[1] 雷章成 陆东亚 蒋宜彪 Liu Zhenbin;Wang Gang;Wang Bowen;Li Menghu;Lei Zhangcheng;Lu Dongya;Jiang Yibiao(National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion/Department of Wound and Vascular Surgery,First Teaching Hospital of Tianjin University of Traditional Chinese Medicine,Tianjin 300381,China)

机构地区：[1]国家中医针灸临床医学研究中心/天津中医药大学第一附属医院疮疡及周围血管外科,天津300381

出　　处：《血管与腔内血管外科杂志》2024年第4期404-407,428,共5页Journal of Vascular and Endovascular Surgery

基　　金：2023年度主题案例项目(ZT-231006331)。

摘　　要：目的探讨髂股静脉支架治疗髂静脉压迫综合征(ILVS)的临床疗效及安全性。方法收集2023年1月至2023年10月于国家中医针灸临床医学研究中心/天津中医药大学第一附属医院成功完成髂股静脉支架置入术的9例髂静脉压迫综合征患者的临床资料。观察所有患者的治疗情况,包括支架置入情况、一期通畅情况、静脉临床严重程度评分(VCSS)、阿伯丁静脉曲张问卷(AVVQ)评分及不良事件发生情况。结果9例患者均成功完成髂股静脉支架置入术。治疗后3个月随访期间,8例患者下肢血流一期通畅,1例患者发生了支架内再狭窄。所有患者术后3个月VCSS、AVVQ评分均低于术前,差异均有统计学意义(P﹤0.05)。随访3个月内未见支架内再狭窄、肺栓塞、血肿、死亡等主要不良事件,无临床驱动的靶病变血管重建。结论髂股静脉支架在髂静脉综合征治疗中的应用效果佳,血管一期通畅良好,术后并发症少。Objective To investigate the clinical efficacy and safety of iliofemoral vein stenting in the treatment of iliac venous compression syndrome(ILVS).Method The clinical data of 9 patients with ILVS who successfully completed iliofemoral vein stenting placement at National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion/First Teaching Hospital of Tianjin University of Traditional Chinese Medicine from January 2023 to October 2023 were collected.The treatment status of all patients,including stent placement,one-stage patency,and venous clinical severity score(VCSS),Aberbeen varicose vein questionnaire(AVVQ)scores and occurrence of adverse events were observed.Result All 9 patients successfully completed the placement of iliofemoral vein stenting.During the 3-month follow-up period after treatment,8 patients had one-stage patency of lower limb blood flow,and 1 patient experienced stent restenosis.The VCSS and AVVQ scores at 3 months after surgery were all lower than those before surgery,and the differences were statistically significant(P<0.05).Within 3 months of follow-up,no major adverse events such as stent restenosis,pulmonary embolism,hematoma,or death were observed,and there was no clinically indicated target-lesion revascularization.Conclusion The application effect of iliac femoral vein stent in the treatment of ILVS is excellent,with favorable primary patency and minimal postoperative complications.

关 键 词：髂股静脉支架 髂静脉压迫综合征 支架内再狭窄 临床疗效 安全性 

分 类 号：R543[医药卫生—心血管疾病]